BIOBIJOU Co., Ltd. Logo

BIOBIJOU Co., Ltd.

Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.

489460 | KO

Overview

Corporate Details

ISIN(s):
KR7489460006
LEI:
Country:
South Korea
Address:
경기도 하남시 하남대로 947 에이동 1516호, 하남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BIOBIJOU Co., Ltd. is a global medical aesthetics company established in 2018. It specializes in the research, development, manufacturing, and sale of injectable products such as skin boosters, hyaluronic acid (HA) fillers, and fat-dissolving solutions, alongside other cosmetic items. The company manages an integrated value chain, from R&D and product design to production in its own GMP-certified facilities and global distribution. BIOBIJOU has established a robust sales network, exporting to over ten countries with a strong presence in the Chinese market. Through strategic R&D alliances and investment in high-level manufacturing, the company aims to deliver high-quality, competitively priced aesthetic solutions to the global market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-05-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.4 KB
2025-05-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.8 KB
2025-05-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.9 KB
2025-05-13 00:00
Share Issue/Capital Change
증권발행실적보고서
Korean 211.9 KB
2025-05-02 00:00
Registration Form
[발행조건확정]증권신고서(지분증권)
Korean 495.1 KB
2025-05-02 00:00
Prospectus
[기재정정]투자설명서
Korean 3.6 MB
2025-04-29 00:00
Prospectus
투자설명서
Korean 3.1 MB
2025-04-18 00:00
Registration Form
[기재정정]증권신고서(지분증권)
Korean 3.1 MB
2025-04-07 00:00
Registration Form
[기재정정]증권신고서(지분증권)
Korean 4.0 MB
2025-03-24 00:00
Annual / Quarterly Financial Statement
[기재정정]감사보고서 (2024.12)
Korean 493.5 KB
2025-03-24 00:00
Annual / Quarterly Financial Statement
[기재정정]연결감사보고서 (2024.12)
Korean 504.6 KB
2025-03-24 00:00
Registration Form
증권신고서(지분증권)
Korean 3.0 MB
2025-03-18 00:00
Annual / Quarterly Financial Statement
감사보고서 (2024.12)
Korean 488.6 KB
2025-03-18 00:00
Audit Report / Information
연결감사보고서 (2024.12)
Korean 499.7 KB

Automate Your Workflow. Get a real-time feed of all BIOBIJOU Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOBIJOU Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOBIJOU Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
Developing cytisinicline, a plant-based treatment for smoking cessation and nicotine addiction.
United States of America
ACHV
AC Immune SA Logo
Developing precision medicine to diagnose, treat, and prevent neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
A clinical-stage biopharma developing novel drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Develops precision cancer therapies by matching patients to drugs using its proteomics platform.
United States of America
ACRV
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Develops targeted radiotherapies for advanced cancers like AML and prostate cancer.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing a novel GSK-3 inhibitor for hard-to-treat cancers.
United States of America
ACTU
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing an antibody therapy for Alzheimer's by targeting toxic AβOs.
United States of America
ABOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.